Trial intelligence / Profile preview

GEM3: Methotrexate plus gefitinib vs methotrexate alone for ectopic pregnancy

2015-005013-76Phase 3Unknown

Sponsor
Accord Healthcare
Start
Mar 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of gefitinib, methotrexate in Ectopic pregnancy (EP), sponsored by Accord Healthcare. Status: unknown.

02

Drugs

gefitinibmethotrexate
03

Conditions

Ectopic pregnancy (EP)

Beyond the preview

Go deeper on 2015-005013-76.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-005013-76.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call